Navigation Links
National Indoor Comfort Week - A Breath of Fresh Air for Allergy Sufferers
Date:4/17/2008

r and need changed more frequently

-- Worsening of allergies or other health issues

Atlas Butler offers a diagnostic test called the AirAdvice Indoor Air Analysis(TM) that samples indoor air and produces a detailed report that shows indoor air impurities. The report also suggests ways homeowners and business can solve their indoor air problems.

For more information on the AirAdvice Indoor Air Analysis(TM) from Atlas Butler, please contact 1-800-FURNACE (1-800-387-6223).

Founded in 1921, Atlas Butler is one of Central Ohio's largest residential and commercial heating, ventilation and air conditioning service companies. The firm employs 105 associates, and serves more than 22,000 residences annually. For more information, visit http://www.atlasbutler.com.


'/>"/>
SOURCE Atlas Butler
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing
2. The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award
3. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
4. Live Webcast of SBAs National Small Business Week Policy Forums Scheduled
5. Statement by SEIU International President Andy Stern Regarding CNA Temporary Restraining Order
6. National Restaurant Association Expresses Disappointment About Court Ruling on Menu Labeling in New York City
7. More Than 350 Events Today in Recognition of First National Healthcare Decisions Day
8. Jenni Schaefer, Motivational Speaker, Author Named National Eating Disorders Association (NEDA) Ambassador
9. China Sky One Medical, Inc. Announces Its Successful Participation in the 20th International Medical Instruments and Equipment Exhibition
10. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
11. Start! Walking America: The American Heart Associations National Start! Walking Day Is April 16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...thority Over Tobacco, WASHINGTON, May 9 /PRNews...c faith-based organization in the country, today a...moking Prevention and Tobacco Control,Act." The le...cco products., "We encourage Congress to pass t... broad bi-partisan support and could genuinely hel...
(Date:5/11/2008)...-- As the global community observes,the destructiv...one of all,time and the associated mounting frustr...ctims, the Alumni Myanmar Institutes of Medicine A...ortantly, successful-in initiating,medical care at... people,are assumed dead. AMIMA has funded the tra...
(Date:5/11/2008)... The winners of today,s Susan G.,Komen Pittsburgh ... Overall Winners Male: Pat McGuire, Charlott...n, Pittsburgh, Pa., 19:19, 2nd Place Overall Winn...Anna Beck, Washington, Pa., 19:22, 3rd Place Over...a., 16:13 Female: Jessica Winter, Pittsburgh...
(Date:5/11/2008)...for Unveiling of the New Name of the ...AGO, May 11 /PRNewswire/ -- Thousands of people ho...y were present for the unveiling of the,new name a...ancer,organization, This year, Y-ME National Brea...nniversary. In celebration of this landmark, Y-ME ...
Breaking Medicine News(10 mins):Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Y-ME Makes Historic Announcement on Mother's Day 2Health News:Y-ME Makes Historic Announcement on Mother's Day 3
...argest drug maker, Pfizer has announced that it in... India. Exubera received regulatory approvals from...uropean Commission last week. The drug has been de...ntis and Nektar Therapeutics. It is a relatively ...
...tions can be caused by shampoos, which are also sa...os were examined, and seven of // them were seen t... rise to skin allergies, according to the German m... six of the shampoos could cause allergic reaction...
...a Crohn’s patient has successfully reached the Vin...ntains. The climb began // on January 12th and was...t days of unpredictable and sub-freezing temperatu...ho was later diagnosed with Crohn's disease and ul...
...aceuticals have come out with a new experimental M...st contracting HIV and the herpes simplex virus. T...rnal // of infectious diseases. Microbicides are ...d sponges that are used to prevent the sexual tran...
Other Medicine News:Health News:Crohn's Patient Robert Hill’s greatest achievemen 2
(Date:5/9/2008)... SAN DIEGO, May 9 /- A... focused on the discovery and development of,small...cancer and,inflammatory diseases, including gout, ...ed Senior Vice President, Finance and Operations a... He will resign from our board of,directors shortl...
(Date:5/9/2008)... - Fifth International Phase III Study Shows Po... Data -, NUTLEY, N.J., May 9 /PRNewswire/ ...ew two-year Phase III study showing that ACTEMRA(T...sion of structural damage to,joints in patients wi...f,effectiveness of an RA treatment. The study also...
(Date:5/8/2008)... CLEVELAND, May 8 /- D...chnology and services company focused on global,eC..., today reported its,operating results for the fir...arch 31, 2008, revenue decreased,approximately 41%... of,$(2,233,000), or $(0.16) per share on both a b...
(Date:5/8/2008)... BOSTON, May 8 /- The Cancer Res... the nation,s top cancer centers, is asking,303 mi...r by donating $1 to,cancer research efforts this M...dubbed the "Infinite Power of One(TM)" has two key...atters into their own hands by,joining together to...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5First Human Implant of New Archus Orthopedics Facet Replacement System 1879 1First Human Implant of New Archus Orthopedics Facet Replacement System 1879 2Scan Detects Oxygen Levels in Tumors 17519 1Scan Detects Oxygen Levels in Tumors 17519 2Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 1Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 2Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 1Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 2Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 3
...Phase III Study Results Presented At ASCO -- , CHI...ent with,pegylated interferon alfa-2b in stage III...n relapse-free survival (RFS),according to the re... in patients with stage III melanoma. Results of t...on for the Research and,Treatment of Cancer (EORTC...
...4, 2007 /PRNewswire/ -- A nationally renowned,canc...arch Network,presented a novel study design concep...ethod to accelerate new agent development.,Studies...ed through,the network,s innovative Translational ...onducts early phase trials in a community,setting....
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 2Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 3Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 4Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 5
For the quantitative in vitro determination of IgE in Human Serum or Plasma.
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum.
For the quantitative in vitro determination of Apolipoprotein B in human serum
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma
Medicine Products: